<p>From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation. At BMS, he’s advancing both in-house AI applications and AI-powered R&D—unlocking hidden data patterns that can turn serendipity into systematic discovery.</p>

From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation. At BMS, he’s advancing both in-house AI applications and AI-powered R&D—unlocking hidden data patterns that can turn serendipity into systematic discovery.

<p>From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation.&nbsp;At BMS, he’s advancing both in-house AI applications and AI-powered R&amp;D—unlocking hidden data patterns that can turn serendipity into systematic discovery.</p>

The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery

Healthcare investment experts Devin O’Reilly and Paul Moskowitz interview innovators at the forefront of healthcare AI. Together, they explore the impacts of AI on healthcare, with a focus on the human experience, operational opportunities, and the future of drug discovery. Learn more about the Bain Capital global healthcare platform at https://www.baincapital.com/healthcare.

Business

Science

Technology

Investing

Life Sciences

Healthcare investment experts Devin O’Reilly and Paul Moskowitz interview innovators at the forefront of healthcare AI. Together, they explore the impacts of AI on healthcare, with a focus on the human experience, operational opportunities, and the future of drug discovery. Learn more about the Bain Capital global healthcare platform at https://www.baincapital.com/healthcare.

Healthcare investment experts&nbsp;Devin O’Reilly&nbsp;and&nbsp;Paul Moskowitz&nbsp;interview innovators at the forefront of healthcare AI. Together, they explore the impacts of AI on healthcare, with a focus on the human experience, operational opportunities, and the future of drug discovery. Learn more about the Bain Capital global healthcare platform at&nbsp;https://www.baincapital.com/healthcare.

Share The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery

Sign up to save your podcasts

The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery

The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery

More shows like The Future of Healthcare AI

Exchanges

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

WSJ What’s News

The McKinsey Podcast

a16z Podcast

NVIDIA AI Podcast

Capital Allocators – Inside the Institutional Investment Industry

The Journal.

Dry Powder: The Private Equity Podcast

All-In with Chamath, Jason, Sacks & Friedberg

Dwarkesh Podcast

Hard Fork

The AI Daily Brief: Artificial Intelligence News and Analysis

The Markets

BG2Pod with Brad Gerstner and Bill Gurley